• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡格列酮可预防糖耐量受损患者的反应性低血糖。

Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance.

作者信息

Arii Kaoru, Ota Kikuko, Suehiro Tadashi, Ikeda Yukio, Nishimura Kanae, Kumon Yoshitaka, Hashimoto Kozo

机构信息

Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.

出版信息

Diabetes Res Clin Pract. 2005 Sep;69(3):305-8. doi: 10.1016/j.diabres.2005.01.004. Epub 2005 Feb 23.

DOI:10.1016/j.diabres.2005.01.004
PMID:16098929
Abstract

A 42-year-old woman with hypoglycemic symptoms that occurred several hours after a meal visited our hospital. The hypoglycemic symptoms appeared when she was 37 years old, and her plasma glucose level had been assessed as less than 60 mg/dL when she experienced the symptoms. One year before, she had been diagnosed with reactive hypoglycemia by 75 g-oral glucose tolerance test (OGTT), which showed a normal glucose tolerance (NGT) pattern, and had begun taking an alpha-glucosidase inhibitor and nutritional treatment. A 75 g-OGTT on admission showed hypoglycemia at 240 min after glucose loading, excessive insulin secretion and an impaired glucose tolerance (IGT) pattern. A euglycemic-hyperinsulinemic clamp study demonstrated decreased insulin sensitivity. Therefore, we suspected that she had reactive hypoglycemia associated with insulin resistance and treated her with 15 mg/day pioglitazone. Her hypoglycemic symptoms completely disappeared after treatment with pioglitazone; insulin sensitivity in a euglycemic-hyperinsulinemic clamp study improved. Another 75 g-OGTT revealed that the excessive insulin secretion and hypoglycemia at 240 min after glucose loading had disappeared, and glucose tolerance was normalized from an IGT pattern to an NGT pattern. Thus, we believe that pioglitazone is effective for reactive hypoglycemia and aggravated glycemic metabolism associated with insulin resistance.

摘要

一名42岁女性,餐后数小时出现低血糖症状,前来我院就诊。低血糖症状在她37岁时出现,症状发作时其血浆葡萄糖水平经评估低于60mg/dL。一年前,她通过75g口服葡萄糖耐量试验(OGTT)被诊断为反应性低血糖,该试验显示葡萄糖耐量正常(NGT)模式,此后她开始服用α-葡萄糖苷酶抑制剂并接受营养治疗。入院时的75g-OGTT显示,葡萄糖负荷后240分钟出现低血糖,胰岛素分泌过多且葡萄糖耐量受损(IGT)模式。正常血糖-高胰岛素钳夹研究显示胰岛素敏感性降低。因此,我们怀疑她患有与胰岛素抵抗相关的反应性低血糖,并给予她每天15mg吡格列酮进行治疗。使用吡格列酮治疗后,她的低血糖症状完全消失;正常血糖-高胰岛素钳夹研究中的胰岛素敏感性得到改善。另一项75g-OGTT显示,葡萄糖负荷后240分钟的胰岛素分泌过多和低血糖现象消失,葡萄糖耐量从IGT模式恢复正常至NGT模式。因此,我们认为吡格列酮对反应性低血糖以及与胰岛素抵抗相关的血糖代谢恶化有效。

相似文献

1
Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance.吡格列酮可预防糖耐量受损患者的反应性低血糖。
Diabetes Res Clin Pract. 2005 Sep;69(3):305-8. doi: 10.1016/j.diabres.2005.01.004. Epub 2005 Feb 23.
2
[Successful treatment of recurrent hypoglycemia by pioglitazone in a patient with myotonic dystrophy].吡格列酮成功治疗一名强直性肌营养不良患者的复发性低血糖症
Rinsho Shinkeigaku. 2009 Oct;49(10):641-5. doi: 10.5692/clinicalneurol.49.641.
3
Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance.吡格列酮对空腹血糖受损和糖耐量受损患者胰岛素分泌的影响。
Diabetes Res Clin Pract. 2007 Jan;75(1):115-8. doi: 10.1016/j.diabres.2006.05.003. Epub 2006 Jun 15.
4
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.空腹血糖受损者存在早期但不存在晚期胰岛素分泌受损。
Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.
5
Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.吡格列酮与二甲双胍对糖耐量受损和早期糖尿病患者胰岛素抵抗及激素指标影响的比较
Hypertens Res. 2007 Jan;30(1):23-30. doi: 10.1291/hypres.30.23.
6
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.在“立即行动”(ACT NOW)研究中,基线脂联素水平不影响对吡格列酮的反应。
Diabetes Care. 2014 Jun;37(6):1706-11. doi: 10.2337/dc13-1745. Epub 2014 Apr 4.
7
The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone.吡格列酮治疗的 IGT 患者的处置指数不能反映β细胞功能。
J Clin Endocrinol Metab. 2014 Oct;99(10):3774-81. doi: 10.1210/jc.2014-1515. Epub 2014 Jun 17.
8
Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.罗格列酮和吡格列酮同样能改善2型糖尿病患者的胰岛素敏感性和分泌、糖耐量及脂肪细胞因子。
Diabetes Obes Metab. 2008 Dec;10(12):1204-11. doi: 10.1111/j.1463-1326.2008.00880.x. Epub 2008 May 12.
9
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.一种用于监测胰岛素敏感性和葡萄糖耐量变化的新型胰岛素抵抗指数:ACT NOW研究。
J Clin Endocrinol Metab. 2015 May;100(5):1855-62. doi: 10.1210/jc.2014-3824. Epub 2015 Jan 20.
10
Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.罗格列酮改善糖耐量受损的非肥胖受试者的胰岛素敏感性:脂联素和C反应蛋白的作用。
Metabolism. 2006 Apr;55(4):439-44. doi: 10.1016/j.metabol.2005.10.004.

引用本文的文献

1
Postprandial Reactive Hypoglycemia.餐后反应性低血糖
Sisli Etfal Hastan Tip Bul. 2019 Aug 28;53(3):215-220. doi: 10.14744/SEMB.2019.59455. eCollection 2019.
2
Nocturnal reactive hypoglycaemia well treated subjectively and objectively with voglibose.伏格列波糖对夜间反应性低血糖有良好的主观及客观治疗效果。
BMJ Case Rep. 2017 Oct 4;2017:bcr-2017-220295. doi: 10.1136/bcr-2017-220295.
3
Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population.中国人口服葡萄糖耐量试验中与生化性低血糖相关的因素。
J Diabetes Res. 2017;2017:3212814. doi: 10.1155/2017/3212814. Epub 2017 Aug 22.